National survey of thrombolytic therapy for acute ischemic stroke in Taiwan 2003-2010

Journal of Stroke and Cerebrovascular Diseases

Volumn 22, Issue 8, 2013, Pages

  Hsieh, Cheng Yang ^a,b   Chen, Chih Hung ^b   Chen, Yi Chi ^c   Kao Yang, Yea Huei ^b,c  

^a TAINAN SIN LAU HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

acute ischemic stroke; Asia; rtPA; Taiwan; Thrombolytic therapy; utilization pattern

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DATA BASE; DEVELOPED COUNTRY; FEMALE; FIBRINOLYTIC THERAPY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NATIONAL HEALTH INSURANCE; NEUROLOGY; PHYSICIAN; PRIORITY JOURNAL; RISK FACTOR; TAIWAN; ADOLESCENT; ADVERSE EFFECTS; CHEMICALLY INDUCED; CLINICAL PRACTICE; HEALTH CARE SURVEY; MASS COMMUNICATION; MIDDLE AGED; RISK; STATISTICAL MODEL; STROKE; TIME; TREATMENT OUTCOME; TRENDS; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

FIBRINOLYTIC AGENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CROSS-SECTIONAL STUDIES; DIFFUSION OF INNOVATION; FIBRINOLYTIC AGENTS; HEALTH CARE SURVEYS; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS; STROKE; TAIWAN; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84889068852     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2013.07.043     Document Type: Article

References (29)

1. F.I. Hsieh, L.M. Lien, and S.T. Chen Get With the Guidelines-Stroke performance indicators: surveillance of stroke care in the Taiwan Stroke Registry: Get With the Guidelines-Stroke in Taiwan Circulation 122 2010 1116 1123
2. J.M. Wardlaw, V. Murray, and E. Berge Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis Lancet 379 2012 2364 2372
3. P. Huang, C.H. Chen, and Y.H. Yang Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: way to endeavor Cerebrovasc Dis 22 2006 423 428
4. P. Huang, G.T. Khor, and C.H. Chen Eligibility and rate of treatment for recombinant tissue plasminogen activator in acute ischemic stroke using different criteria Acad Emerg Med 18 2011 273 278
5. Y.C. Hsu, S.F. Sung, and C.T. Ong Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital Acta Neurol Taiwan 18 2009 14 20
6. M. Eriksson, F. Jonsson, and P. Appelros Dissemination of thrombolysis for acute ischemic stroke across a nation: experiences from the Swedish stroke register, 2003 to 2008 Stroke 41 2010 1115 1122
7. O. Adeoye, R. Hornung, and P. Khatri Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years Stroke 42 2011 1952 1955
8. V.K. Sharma, K.W. Ng, and N. Venketasubramanian Current status of intravenous thrombolysis for acute ischemic stroke in Asia Int J Stroke 6 2011 523 530
9. S. Ueshima, and O. Matsuo The differences in thrombolytic effects of administrated recombinant t-PA between Japanese and Caucasians Thromb Haemost 87 2002 544 546
10. Bureau of National Health Insurance, Taiwan. NHI Profile: Universal Health Coverage in Taiwan [updated 28 Jan 2013; cited 6 Apr 2013]. Available at: http://www.nhi.gov.tw/Resource/webdata/21717-1-20120808UniversalHealthCoverage. pdf.
11. National Health Research Institute, Taiwan. National Health Insurance Research Database [updated 12 Dec 2012; cited 6 Apr 2013]. Available at: http://www.nhri.org.tw/nhird/en/index.htm.
12. C.L. Cheng, Y.C. Chen, and T.M. Liu Using spatial analysis to demonstrate the heterogeneity of the cardiovascular drug-prescribing pattern in Taiwan BMC public health 11 2011 380
13. L.B. Goldstein, G.P. Samsa, and D.B. Matchar Charlson Index comorbidity adjustment for ischemic stroke outcome studies Stroke 35 2004 1941 1945
14. W.T. Chiu, C.M. Yang, and H.W. Lin Development and implementation of a nationwide health care quality indicator system in Taiwan Int J Qual Health Care 19 2007 21 28
15. A. Alshekhlee, A. Mohammadi, and S. Mehta Is thrombolysis safe in the elderly?: analysis of a national database Stroke 41 2010 2259 2264
16. P.U. Heuschmann, K. Berger, and B. Misselwitz Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group Stroke 34 2003 1106 1113
17. Y. Wang, X. Liao, and X. Zhao Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR) Stroke 42 2011 1658 1664
18. T.H. Nguyen, A.L. Truong, and M.B. Ngo Patients with thrombolysed stroke in Vietnam have an excellent outcome: results from the Vietnam Thrombolysis Registry Eur J Neurol: 17 2010 1188 1192
19. B.C. Lee, and J.K. Roh International experience in stroke registries: Korean Stroke Registry Am J Prev Med 31 2006 S243 S245
20. S. Sato, T. Uehara, and K. Toyoda Impact of the approval of intravenous recombinant tissue plasminogen activator therapy on the processes of acute stroke management in Japan: the Stroke Unit Multicenter Observational (SUMO) Study Stroke 40 2009 30 34
21. K.R. Evenson, R.E. Foraker, and D.L. Morris A comprehensive review of prehospital and in-hospital delay times in acute stroke care Int J Stroke 4 2009 187 199
22. S. Prabhakaran, M. McNulty, and K. O'Neill Intravenous thrombolysis for stroke increases over time at primary stroke centers Stroke 43 2012 875 877
23. J.S. Jeng, S.C. Tang, and I.C. Deng Stroke center characteristics which influence the administration of thrombolytic therapy for acute ischemic stroke: a national survey of stroke centers in Taiwan J Neurol Sci 281 2009 24 27
24. C.Y. Wu, H.J. Lai, and R.C. Chen Patient characteristics predict occurrence and outcome of complaints against physicians: a study from a medical center in central Taiwan J Formos Med Assoc 108 2009 126 134
25. S.D. Reed, S.C. Cramer, and D.K. Blough Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals Stroke 32 2001 1832 1840
26. H.C. Schumacher, B.T. Bateman, and B. Boden-Albala Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004 Ann Emerg Med 50 2007 99 107
27. B.L. Hoh, Y.Y. Chi, and M.F. Waters Effect of weekend compared with weekday stroke admission on thrombolytic use, in-hospital mortality, discharge disposition, hospital charges, and length of stay in the Nationwide Inpatient Sample Database, 2002 to 2007 Stroke 41 2010 2323 2328
28. E. Palomeras, P. Fossas, and M. Quintana Emergency perception and other variables associated with extra-hospital delay in stroke patients in the Maresme region (Spain) Eur J Neurol 15 2008 329 335
29. G.J. Jungehulsing, K. Rossnagel, and C.H. Nolte Emergency department delays in acute stroke - analysis of time between ED arrival and imaging Eur J Neurol 13 2006 225 232